Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1701 - 1725 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▼
Gangliosides LMSP0601EE01
  • NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • sialyl-Lex(d18:1/16:0)
44262780 1663.903272 C77H137N3O35
Diacylglycerophosphoinositolglycans LMGP15010245
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(16:0/16:2(9Z,12Z))
126457613 1778.811483 C77H135O43P
Diacylglycerophosphoinositolglycans LMGP15010266
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(18:2(9Z,12Z)/14:0)
126457634 1778.811483 C77H135O43P
LMSL03001285
  • 2-O-hexadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R,18R,20R-decamethyl)-21-hydroxy-octatriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(16:0/38:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[S],12Me[R],14Me[R],16Me[R],18Me[R],20Me[R],21OH))
126457726 1363.028077 C76H146O17S
LMSL03001296
  • 2-O-octadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R,18R,20R-decamethyl)-21-hydroxy-hexatriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(18:0/36:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[S],12Me[R],14Me[R],16Me[R],18Me[R],20Me[R],21OH))
126457737 1363.028077 C76H146O17S
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE06
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • SSEA-3 antigen(d18:1/26:0)
44260201 1528.959268 C76H140N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AP06
  • GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260289 1528.959268 C76H140N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BA06
  • Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260377 1528.959268 C76H140N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BK06
  • Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260457 1528.959268 C76H140N2O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AJ06
  • Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260561 1528.959268 C76H140N2O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AQ06
  • Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260745 1528.959268 C76H140N2O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504BU06
  • Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260969 1528.959268 C76H140N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AC06
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260993 1528.959268 C76H140N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BJ06
  • Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • galgactosyl-paraglobside(d18:1/26:0)
44261257 1528.959268 C76H140N2O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BK06
  • Galalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261265 1528.959268 C76H140N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AN06
  • Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261921 1528.959268 C76H140N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AS06
  • Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • iGb5(d18:1/26:0)
44261585 1528.959268 C76H140N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AU06
  • Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261601 1528.959268 C76H140N2O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BE06
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261665 1528.959268 C76H140N2O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AI06
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260553 1512.964353 C76H140N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AC06
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Lewis a(d18:1/26:0)
44260633 1512.964353 C76H140N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AD06
  • Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • type I H antigen(d18:1/26:0)
44260641 1512.964353 C76H140N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AB06
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Lex-5(d18:1/26:0)
44260985 1512.964353 C76H140N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AD06
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • type II antigen(d18:1/26:0)
44261001 1512.964353 C76H140N2O27
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AV06
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261609 1512.964353 C76H140N2O27

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024